STEPHEN SPRINGER: Open Payments
NPI 1518979657 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$449 in 20 payments from 8 companies in 2025. Trend: 2023 $1,525 · 2024 $1,403 · 2025 $449
Food & beverage: $449
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $233 |
| Galderma Laboratories, L.P. | 2 | $63 |
| Novartis Pharmaceuticals Corporation | 2 | $40 |
| Incyte Corporation | 2 | $31 |
| GENZYME CORPORATION | 1 | $27 |
| Janssen Biotech, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
| PFIZER INC. | 1 | $16 |
Products named: SKYRIZI, NEMLUVIO, OPZELURA, DUPIXENT, COSENTYX, TREMFYA, TALTZ, CIBINQO.
Industry payments across TX — which companies pay providers there.
